SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001102624-12-000454
Filing Date
2012-05-18
Accepted
2012-05-18 16:34:24
Documents
11
Period of Report
2012-03-31
Filing Date Changed
2012-05-18

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-Q bostontherapeutics10q.htm 10-Q 402317
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 18548
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 18694
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 7401
5 EXHIBIT 32.2 exh32_2.htm EX-32.2 7414
  Complete submission text file 0001102624-12-000454.txt   1300517

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bstn-20120331.xml EX-101.INS 80315
7 XBRL TAXONOMY EXTENSION SCHEMA bstn-20120331.xsd EX-101.SCH 8433
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstn-20120331_cal.xml EX-101.CAL 24275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstn-20120331_def.xml EX-101.DEF 5856
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstn-20120331_lab.xml EX-101.LAB 78333
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstn-20120331_pre.xml EX-101.PRE 54423
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 12856000
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1